PFM Health Sciences’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PFM Health Sciences’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-717,400	Closed	-$71.9M	–	103
2025 Q3	$71.9M	Buy	+717,400	New	+$64.6M	5.53%	3
2024 Q4	–	Sell	-218,200	Closed	-$21.6M	–	100
2024 Q3	$21.6M	Sell	218,200 -376,300	-63%	-$37M	1.22%	28
2024 Q2	$55.1M	Buy	+594,500	New	+$53.3M	2.73%	11
2021 Q2	–	Sell	-350,000	Closed	-$47.5M	–	99
2021 Q1	$47.5M	Buy	+350,000	New	+$52.4M	1.45%	23
2017 Q4	–	Sell	-2,126,900	Closed	-$184M	–	103
2017 Q3	$184M	Buy	+2,126,900	New	+$171M	3.62%	4
2017 Q1	–	Sell	-250,900	Closed	-$14.9M	–	120
2016 Q4	$14.9M	Buy	+250,900	New	+$15.5M	0.42%	66
2016 Q2	–	Sell	-544,000	Closed	-$28.1M	–	103
2016 Q1	$28.1M	Buy	+544,000	New	+$28.3M	0.87%	39

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PFM Health Sciences's XBI Position: Q4 2024 in Review

PFM Health Sciences sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 121,845 shares — an estimated $11.8M sold.

PFM Health Sciences first reported a position in XBI in Q4 2016 and held it in 3 quarters. The position peaked at $39.9M in Q3 2017. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

PFM Health Sciences reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
PFM Health Sciences sold 121,845 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $11.8M.
PFM Health Sciences first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 3 quarters.
PFM Health Sciences's State Street SPDR S&P Biotech ETF position peaked at $39.9M in Q3 2017.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on PFM Health Sciences's 13F filing for Q4 2024, filed 14 Feb 2025.